Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 27 | 2020 | 3500 | 2.570 |
Why?
|
| Isoflurane | 11 | 2020 | 64 | 2.540 |
Why?
|
| Somatosensory Cortex | 7 | 2019 | 150 | 2.080 |
Why?
|
| Rabbits | 32 | 2020 | 642 | 1.960 |
Why?
|
| Brain | 25 | 2020 | 2327 | 1.720 |
Why?
|
| Anesthetics, Inhalation | 7 | 2019 | 97 | 1.700 |
Why?
|
| Magnetic Resonance Spectroscopy | 22 | 2014 | 315 | 1.530 |
Why?
|
| Oxygen | 7 | 2019 | 746 | 1.480 |
Why?
|
| Blinking | 5 | 2020 | 17 | 1.200 |
Why?
|
| Conditioning, Classical | 5 | 2020 | 37 | 1.190 |
Why?
|
| Vibrissae | 5 | 2016 | 11 | 1.130 |
Why?
|
| Blast Injuries | 3 | 2020 | 12 | 1.020 |
Why?
|
| Evoked Potentials, Somatosensory | 2 | 2016 | 34 | 0.970 |
Why?
|
| Physical Stimulation | 6 | 2016 | 72 | 0.900 |
Why?
|
| Artifacts | 5 | 2013 | 246 | 0.830 |
Why?
|
| Brain Mapping | 5 | 2015 | 573 | 0.800 |
Why?
|
| Neurons | 6 | 2019 | 1597 | 0.770 |
Why?
|
| Animals | 50 | 2020 | 27783 | 0.760 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2020 | 71 | 0.740 |
Why?
|
| Wakefulness | 3 | 2016 | 135 | 0.740 |
Why?
|
| Corpus Callosum | 2 | 2020 | 59 | 0.720 |
Why?
|
| Hippocampus | 2 | 2020 | 442 | 0.710 |
Why?
|
| Anesthesia, General | 1 | 2020 | 118 | 0.660 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 51 | 0.630 |
Why?
|
| White Matter | 1 | 2020 | 85 | 0.630 |
Why?
|
| Brain Waves | 1 | 2019 | 32 | 0.630 |
Why?
|
| Image Enhancement | 4 | 2015 | 566 | 0.630 |
Why?
|
| Neural Inhibition | 1 | 2019 | 98 | 0.620 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 698 | 0.610 |
Why?
|
| Halothane | 8 | 1996 | 12 | 0.570 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2020 | 105 | 0.570 |
Why?
|
| Echo-Planar Imaging | 3 | 2004 | 52 | 0.570 |
Why?
|
| Cerebral Cortex | 4 | 2019 | 592 | 0.570 |
Why?
|
| Conditioning, Eyelid | 2 | 2008 | 3 | 0.550 |
Why?
|
| Anesthesia | 2 | 2016 | 167 | 0.530 |
Why?
|
| Action Potentials | 2 | 2019 | 605 | 0.530 |
Why?
|
| Mental Disorders | 1 | 2020 | 419 | 0.530 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2015 | 203 | 0.520 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2016 | 1263 | 0.500 |
Why?
|
| Computer Graphics | 1 | 2015 | 100 | 0.470 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 122 | 0.460 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 320 | 0.440 |
Why?
|
| Biomimetic Materials | 1 | 2013 | 24 | 0.440 |
Why?
|
| Algorithms | 5 | 2015 | 1933 | 0.430 |
Why?
|
| Support Vector Machine | 2 | 2014 | 23 | 0.410 |
Why?
|
| Visual Cortex | 2 | 2008 | 255 | 0.380 |
Why?
|
| Animals, Newborn | 4 | 2020 | 523 | 0.370 |
Why?
|
| Plaque, Amyloid | 1 | 2011 | 61 | 0.370 |
Why?
|
| Microscopy | 1 | 2011 | 89 | 0.360 |
Why?
|
| Pancreas | 3 | 2011 | 254 | 0.360 |
Why?
|
| Female | 24 | 2020 | 47186 | 0.320 |
Why?
|
| Brain Concussion | 2 | 2020 | 66 | 0.320 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 2416 | 0.300 |
Why?
|
| Sensitivity and Specificity | 5 | 2015 | 2020 | 0.280 |
Why?
|
| Nitroimidazoles | 1 | 2006 | 8 | 0.270 |
Why?
|
| Fluorine Radioisotopes | 1 | 2006 | 25 | 0.270 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 174 | 0.250 |
Why?
|
| Alzheimer Disease | 2 | 2017 | 520 | 0.250 |
Why?
|
| Behavioral Sciences | 1 | 2005 | 3 | 0.240 |
Why?
|
| Neurophysiology | 1 | 2005 | 14 | 0.240 |
Why?
|
| Fiber Optic Technology | 1 | 2005 | 36 | 0.240 |
Why?
|
| Neoplasms, Experimental | 1 | 2006 | 270 | 0.240 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 2785 | 0.230 |
Why?
|
| Anisotropy | 3 | 2020 | 64 | 0.230 |
Why?
|
| Electrophysiology | 1 | 2005 | 402 | 0.230 |
Why?
|
| Brain Chemistry | 2 | 2000 | 121 | 0.220 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2020 | 1226 | 0.210 |
Why?
|
| Male | 19 | 2020 | 43249 | 0.200 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2002 | 145 | 0.200 |
Why?
|
| Mice | 10 | 2020 | 11993 | 0.200 |
Why?
|
| Cerebellum | 1 | 2003 | 250 | 0.190 |
Why?
|
| Adipose Tissue | 2 | 2014 | 263 | 0.190 |
Why?
|
| Rats | 5 | 2020 | 4043 | 0.190 |
Why?
|
| Body Water | 1 | 2001 | 35 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2001 | 39 | 0.180 |
Why?
|
| Electrodes, Implanted | 2 | 2019 | 189 | 0.180 |
Why?
|
| Brain Edema | 1 | 2001 | 61 | 0.180 |
Why?
|
| Axons | 2 | 2020 | 182 | 0.180 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2006 | 1095 | 0.180 |
Why?
|
| Intracranial Hypertension | 1 | 2001 | 58 | 0.180 |
Why?
|
| Placenta Diseases | 1 | 2019 | 13 | 0.170 |
Why?
|
| Trifluridine | 1 | 1999 | 6 | 0.170 |
Why?
|
| Geniculate Bodies | 1 | 2000 | 140 | 0.170 |
Why?
|
| Antimetabolites | 1 | 1999 | 24 | 0.170 |
Why?
|
| Visual Pathways | 1 | 2000 | 153 | 0.170 |
Why?
|
| Organ Size | 1 | 2020 | 375 | 0.160 |
Why?
|
| Beta Rhythm | 1 | 2019 | 19 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 3303 | 0.150 |
Why?
|
| Phantoms, Imaging | 4 | 2004 | 467 | 0.150 |
Why?
|
| Placenta | 1 | 2019 | 186 | 0.150 |
Why?
|
| Fluorine | 6 | 1996 | 17 | 0.140 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2017 | 12 | 0.140 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 1589 | 0.140 |
Why?
|
| Optogenetics | 1 | 2016 | 37 | 0.130 |
Why?
|
| Semiconductors | 1 | 2015 | 11 | 0.120 |
Why?
|
| Anesthetics, Intravenous | 1 | 2015 | 41 | 0.120 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 2 | 2008 | 243 | 0.120 |
Why?
|
| Thalamus | 1 | 2016 | 134 | 0.120 |
Why?
|
| Computer Systems | 1 | 2015 | 79 | 0.120 |
Why?
|
| Fentanyl | 1 | 2015 | 71 | 0.120 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 91 | 0.120 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 33 | 0.120 |
Why?
|
| Analysis of Variance | 1 | 2016 | 897 | 0.120 |
Why?
|
| Tissue Distribution | 3 | 2006 | 293 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2020 | 2510 | 0.110 |
Why?
|
| Evoked Potentials | 1 | 2015 | 191 | 0.110 |
Why?
|
| Renin-Angiotensin System | 1 | 2014 | 80 | 0.110 |
Why?
|
| Methoxyflurane | 2 | 1983 | 3 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2014 | 141 | 0.110 |
Why?
|
| Equipment Design | 1 | 2015 | 420 | 0.110 |
Why?
|
| Cerebrospinal Fluid | 1 | 2013 | 31 | 0.110 |
Why?
|
| Injections | 1 | 2013 | 116 | 0.110 |
Why?
|
| Memory | 2 | 2008 | 222 | 0.110 |
Why?
|
| Receptors, Calcitriol | 1 | 2014 | 130 | 0.110 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 1757 | 0.100 |
Why?
|
| Learning | 2 | 2008 | 290 | 0.100 |
Why?
|
| Cytosine Nucleotides | 4 | 1976 | 8 | 0.100 |
Why?
|
| Vibration | 1 | 2012 | 49 | 0.100 |
Why?
|
| Deoxyglucose | 1 | 1991 | 37 | 0.100 |
Why?
|
| Colitis | 1 | 2014 | 251 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2014 | 499 | 0.090 |
Why?
|
| Erythrocytes | 3 | 1995 | 255 | 0.090 |
Why?
|
| Blood Vessels | 1 | 2011 | 94 | 0.090 |
Why?
|
| User-Computer Interface | 1 | 2012 | 187 | 0.090 |
Why?
|
| Endothelial Cells | 1 | 2014 | 471 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2012 | 234 | 0.090 |
Why?
|
| Taurine | 2 | 2000 | 11 | 0.090 |
Why?
|
| Anesthetics | 1 | 1991 | 53 | 0.090 |
Why?
|
| Photic Stimulation | 2 | 2005 | 504 | 0.090 |
Why?
|
| Aspartic Acid | 2 | 2000 | 64 | 0.090 |
Why?
|
| Creatine | 2 | 2000 | 26 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 410 | 0.090 |
Why?
|
| Ribonucleases | 4 | 1976 | 93 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 572 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2000 | 85 | 0.080 |
Why?
|
| Protons | 2 | 2000 | 101 | 0.080 |
Why?
|
| Glutamic Acid | 2 | 2000 | 154 | 0.080 |
Why?
|
| Kinetics | 6 | 1995 | 1548 | 0.080 |
Why?
|
| Recruitment, Neurophysiological | 1 | 2008 | 3 | 0.080 |
Why?
|
| Biomarkers | 3 | 2020 | 1814 | 0.080 |
Why?
|
| Time Factors | 4 | 2008 | 5378 | 0.070 |
Why?
|
| Prosencephalon | 1 | 2008 | 65 | 0.070 |
Why?
|
| Aging | 2 | 2005 | 732 | 0.070 |
Why?
|
| Islets of Langerhans | 1 | 2011 | 553 | 0.070 |
Why?
|
| Muscles | 2 | 1989 | 192 | 0.070 |
Why?
|
| Pattern Recognition, Automated | 1 | 2009 | 221 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 577 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 9411 | 0.070 |
Why?
|
| Magnetics | 2 | 2008 | 41 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 989 | 0.070 |
Why?
|
| Half-Life | 3 | 1995 | 97 | 0.070 |
Why?
|
| Sensation Disorders | 1 | 2006 | 24 | 0.070 |
Why?
|
| Muscle Hypertonia | 1 | 2006 | 17 | 0.070 |
Why?
|
| Contrast Media | 1 | 2011 | 1085 | 0.060 |
Why?
|
| Humans | 12 | 2020 | 91073 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2006 | 371 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2006 | 52 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 304 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2008 | 231 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2006 | 309 | 0.060 |
Why?
|
| Cerebral Palsy | 1 | 2006 | 98 | 0.060 |
Why?
|
| Smell | 1 | 2006 | 113 | 0.060 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 353 | 0.060 |
Why?
|
| Optical Fibers | 1 | 2005 | 3 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 687 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 1049 | 0.060 |
Why?
|
| Oligodendroglia | 1 | 2005 | 124 | 0.060 |
Why?
|
| Cornea | 1 | 2005 | 70 | 0.060 |
Why?
|
| Cerebellar Nuclei | 1 | 2003 | 6 | 0.060 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 14 | 0.060 |
Why?
|
| Data Display | 1 | 2003 | 23 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 1102 | 0.060 |
Why?
|
| Microcomputers | 1 | 2003 | 26 | 0.060 |
Why?
|
| Methyl Ethers | 1 | 1983 | 33 | 0.050 |
Why?
|
| Reaction Time | 1 | 2005 | 312 | 0.050 |
Why?
|
| Cognition | 1 | 2008 | 591 | 0.050 |
Why?
|
| Phosphorus Isotopes | 2 | 2000 | 24 | 0.050 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 1806 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2019 | 300 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2008 | 606 | 0.050 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 2001 | 8 | 0.050 |
Why?
|
| Ammonia | 1 | 2001 | 42 | 0.050 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2000 | 28 | 0.050 |
Why?
|
| Choline | 1 | 2000 | 24 | 0.050 |
Why?
|
| Threonine | 1 | 2000 | 35 | 0.050 |
Why?
|
| Restraint, Physical | 1 | 2000 | 28 | 0.040 |
Why?
|
| Down Syndrome | 1 | 2000 | 55 | 0.040 |
Why?
|
| Freezing Reaction, Cataleptic | 1 | 2020 | 3 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2003 | 383 | 0.040 |
Why?
|
| Alanine | 1 | 2000 | 85 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2000 | 96 | 0.040 |
Why?
|
| Explosions | 1 | 2020 | 6 | 0.040 |
Why?
|
| Reference Values | 1 | 2001 | 662 | 0.040 |
Why?
|
| Chloroform | 1 | 1999 | 3 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2000 | 997 | 0.040 |
Why?
|
| Thymidine Phosphorylase | 1 | 1999 | 5 | 0.040 |
Why?
|
| Phosphatidylinositols | 1 | 1999 | 21 | 0.040 |
Why?
|
| Methanol | 1 | 1999 | 11 | 0.040 |
Why?
|
| Monitoring, Physiologic | 1 | 2001 | 265 | 0.040 |
Why?
|
| Fear | 1 | 2020 | 80 | 0.040 |
Why?
|
| Phosphatidylcholines | 1 | 1999 | 50 | 0.040 |
Why?
|
| Software | 1 | 2003 | 670 | 0.040 |
Why?
|
| Phosphorus | 1 | 1999 | 117 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 1999 | 75 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 403 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 1559 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1695 | 0.040 |
Why?
|
| Visual Perception | 1 | 2000 | 328 | 0.030 |
Why?
|
| Pregnancy | 2 | 2019 | 3079 | 0.030 |
Why?
|
| Pyrimidines | 1 | 1999 | 372 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 59 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2017 | 78 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2017 | 198 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2001 | 1892 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1877 | 0.030 |
Why?
|
| Snail Family Transcription Factors | 1 | 2014 | 47 | 0.030 |
Why?
|
| Arteries | 1 | 1995 | 179 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 1222 | 0.030 |
Why?
|
| Adiposity | 1 | 2014 | 76 | 0.030 |
Why?
|
| Angiotensin II | 1 | 2014 | 93 | 0.030 |
Why?
|
| Trifluoroacetic Acid | 1 | 1993 | 2 | 0.030 |
Why?
|
| Solutions | 1 | 1993 | 84 | 0.030 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 81 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 103 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 169 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2014 | 376 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2014 | 570 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2012 | 37 | 0.030 |
Why?
|
| ROC Curve | 1 | 2014 | 785 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 982 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 455 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 165 | 0.020 |
Why?
|
| Rhamnose | 1 | 1991 | 4 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2014 | 476 | 0.020 |
Why?
|
| Macrophages | 1 | 2014 | 589 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 887 | 0.020 |
Why?
|
| Phosphates | 1 | 1991 | 161 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1991 | 143 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 784 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1976 | 499 | 0.020 |
Why?
|
| Lipoproteins | 1 | 1990 | 137 | 0.020 |
Why?
|
| Homeostasis | 1 | 2012 | 429 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2053 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 1989 | 36 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1989 | 311 | 0.020 |
Why?
|
| Ethers | 1 | 2008 | 14 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 49 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 18 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2008 | 16 | 0.020 |
Why?
|
| KRIT1 Protein | 1 | 2008 | 62 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 74 | 0.020 |
Why?
|
| Lasers | 1 | 2008 | 106 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 2615 | 0.020 |
Why?
|
| Fluorocarbons | 1 | 2008 | 71 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 80 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2904 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 2375 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1987 | 94 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2008 | 184 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1991 | 1935 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 211 | 0.020 |
Why?
|
| Skull | 1 | 1989 | 259 | 0.020 |
Why?
|
| Adult | 3 | 2019 | 27147 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2006 | 63 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1987 | 285 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2006 | 14 | 0.020 |
Why?
|
| Manganese | 1 | 2006 | 56 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2014 | 1671 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 925 | 0.020 |
Why?
|
| Olfactory Bulb | 1 | 2006 | 41 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2006 | 79 | 0.020 |
Why?
|
| Odorants | 1 | 2006 | 71 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 3825 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 424 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 9399 | 0.020 |
Why?
|
| Epithelium | 1 | 2006 | 323 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2008 | 667 | 0.010 |
Why?
|
| Mathematics | 2 | 1974 | 191 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 278 | 0.010 |
Why?
|
| Middle Aged | 3 | 2014 | 26555 | 0.010 |
Why?
|
| Sciatic Nerve | 1 | 1983 | 34 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 6847 | 0.010 |
Why?
|
| Plasma | 1 | 1983 | 51 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 3442 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2006 | 1131 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1990 | 1087 | 0.010 |
Why?
|
| Dogs | 1 | 1983 | 704 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2006 | 1093 | 0.010 |
Why?
|
| Protein Binding | 3 | 1976 | 1508 | 0.010 |
Why?
|
| Species Specificity | 1 | 1983 | 690 | 0.010 |
Why?
|
| Phosphoenolpyruvate | 1 | 1981 | 1 | 0.010 |
Why?
|
| Protein Conformation | 2 | 1974 | 903 | 0.010 |
Why?
|
| Erythrocyte Membrane | 1 | 1981 | 61 | 0.010 |
Why?
|
| Binding Sites | 2 | 1974 | 1127 | 0.010 |
Why?
|
| Hypoxia | 1 | 2006 | 660 | 0.010 |
Why?
|
| Aged | 2 | 2014 | 19574 | 0.010 |
Why?
|
| Uracil Nucleotides | 1 | 1976 | 5 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 6502 | 0.010 |
Why?
|
| Polynucleotides | 1 | 1974 | 17 | 0.010 |
Why?
|
| Models, Structural | 1 | 1974 | 58 | 0.010 |
Why?
|
| Chemistry | 1 | 1974 | 54 | 0.010 |
Why?
|
| Glycosides | 1 | 1974 | 21 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1974 | 72 | 0.010 |
Why?
|
| Deuterium | 1 | 1974 | 33 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1974 | 102 | 0.010 |
Why?
|
| Catalysis | 1 | 1974 | 209 | 0.010 |
Why?
|
| Cattle | 1 | 1974 | 379 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1974 | 429 | 0.010 |
Why?
|
| Temperature | 1 | 1974 | 404 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1974 | 345 | 0.010 |
Why?
|
| Lipids | 1 | 1990 | 276 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1990 | 1066 | 0.000 |
Why?
|
| Sodium Fluoride | 1 | 1981 | 3 | 0.000 |
Why?
|
| Diphosphoglyceric Acids | 1 | 1981 | 10 | 0.000 |
Why?
|
| Biological Transport, Active | 1 | 1981 | 102 | 0.000 |
Why?
|